Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
Long-term cost-effectiveness of clopidogrel in STEMI patients
International Journal of Cardiology, 06/29/09
Zhang Z et al. - Addition of clopidogrel to aspirin, given up to 1 year, in the setting of STEMI is a highly cost-effective strategy.
Related Articles
A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
The American Journal of Cardiology, 10/28/09
Relevance Score: 89%
Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09
Relevance Score: 89%
Gender and Responses to Aspirin and Clopidogrel: Insights Using Short Thrombelastography
Cardiovascular Drug Reviews, 11/17/09
Relevance Score: 87%
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Vascular Health and Risk Management, 10/22/09
Relevance Score: 87%
Effects of clopidogrel on aspirin specific pathways of platelet inhibition
Platelets, 10/02/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis
Anti-Cancer Drugs, 12/09/09
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/09/09
Cyclooxygenase inhibitors: Scope of their use and development in cancer chemotherapy
Medicinal Research Reviews, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


